Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell-February 2024-www.financetom.com

Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Edgewise's Phase 2 Trial of Sevasemten to Treat Becker Muscular Dystrophy Meets Primary Endpoint; Shares Up 22% Pre-Bell

Dec 16, 2024 5:13 AM

07:55 AM EST, 12/16/2024 (MT Newswires) -- Edgewise Therapeutics ( EWTX ) said Monday that a phase 2 trial of sevasemten to treat patients with Becker muscular dystrophy met its primary endpoint of change from baseline in creatine kinase.

The biopharmaceutical company also said the key secondary endpoint of function demonstrated an improving trend over time in the sevasemten-treated group. It added the drug was well-tolerated, with no new safety concerns in adult or adolescent patients.

Shares of Edgewise Therapeutics ( EWTX ) were up 22% in recent premarket activity.

Previous page： Air Canada raises core profit forecast on robust international demand Next page： Apple Fiscal Fourth-Quarter Results Top Views Despite $10.2 Billion Tax Charge

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Air Canada raises core profit forecast on robust international demand

Nov 4, 2024

(Reuters) -Air Canada raised its annual core profit forecast on Friday, as the country's largest carrier benefits from strong demand for international travel. Major North American carriers with international operations are cashing in on a booming demand for overseas travel and a resurgence in business bookings. Air Canada is increasing its daily flights to China, while also adding capacity to...

Apple Fiscal Fourth-Quarter Results Top Views Despite $10.2 Billion Tax Charge

Nov 4, 2024

06:44 AM EDT, 11/01/2024 (MT Newswires) -- Apple ( AAPL ) late Thursday reported better-than-expected fiscal fourth-quarter results amid higher iPhone and Mac sales, while the technology giant incurred a one-time tax charge of $10.2 billion related to a European court order in September. Adjusted earnings came in at $1.64 per share for the three-month period ended Sept. 28. The...

A year on, Intel's touted AI-chip deals have fallen short

Nov 4, 2024

(Reuters) - Intel's ( INTC ) upbeat revenue projections on Thursday masked a sore point for the embattled company: chips touted for artificial intelligence have not lived up to sales expectations. The chipmaker scrapped its recent forecast that in 2024 it would sell more than $500 million worth of Gaudi accelerator chips, so called because they speed up the performance...

Air Canada raises core profit forecast on robust international demand

Nov 4, 2024

Nov 1 (Reuters) - Air Canada ( ACDVF ) raised its annual core profit forecast on Friday, as the country's largest carrier benefits from strong demand for international travel and a rebound in business bookings. The carrier now expects its 2024 adjusted earnings before interest, taxes, depreciation and amortization of about C$3.5 billion ($2.51 billion), compared with its previous forecast...